Tianjin Holder Pharmaceutical Technology Co., Ltd, established in 2019, is a service provider offering CRO and CDMO contract research and manufacturing services to pharmaceutical clients. The company supports OEM, ODM, and own-brand development, sells into Western Europe, Eastern Europe, and Asia, and positions itself on international approvals and standards, an experienced R&D staff, a large product line, and quality service.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen